Literature DB >> 19535449

Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides.

Yang Wang1, Inge E A Flesch, David C Tscharke.   

Abstract

Heterologous prime-boost is a common vaccination strategy to elicit CD8(+) T cells (T(CD8+)), and vaccinia virus (VACV) has been widely used as a boosting vector. Studies with other viruses have suggested that priming may reduce responses to native epitopes in boosting vectors as well as improve responses to primed epitopes. We explored this possibility with a VACV model in mice and find that irrespective of an epitope's dominance, prior priming was able to double T(CD8+) responses. More surprisingly, and in contrast to findings for other viruses, responses to remaining epitopes were undisturbed, leaving the overall dominance hierarchy unchanged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535449      PMCID: PMC2738161          DOI: 10.1128/JVI.00410-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 2.  Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design.

Authors:  Jonathan W Yewdell; S M Mansour Haeryfar
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 3.  Dominance and crypticity of T cell antigenic determinants.

Authors:  E E Sercarz; P V Lehmann; A Ametani; G Benichou; A Miller; K Moudgil
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 4.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

5.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

6.  Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.

Authors:  Fernando Rodriguez; Stephanie Harkins; Mark K Slifka; J Lindsay Whitton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

Authors:  Samuel J McConkey; William H H Reece; Vasee S Moorthy; Daniel Webster; Susanna Dunachie; Geoff Butcher; Jenni M Vuola; Tom J Blanchard; Philip Gothard; Kate Watkins; Carolyn M Hannan; Simone Everaere; Karen Brown; Kent E Kester; James Cummings; Jackie Williams; D Gray Heppner; Ansar Pathan; Katie Flanagan; Nirmalan Arulanantham; Mark T M Roberts; Michael Roy; Geoffrey L Smith; Joerg Schneider; Tim Peto; Robert E Sinden; Sarah C Gilbert; Adrian V S Hill
Journal:  Nat Med       Date:  2003-05-25       Impact factor: 53.440

8.  Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models.

Authors:  Jonathan W Yewdell; Margarita Del Val
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

9.  Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Authors:  Jonathan D Silk; Ian F Hermans; Uzi Gileadi; Tsung Wen Chong; Dawn Shepherd; Mariolina Salio; Bini Mathew; Richard R Schmidt; Sarah Jane Lunt; Kaye J Williams; Ian J Stratford; Adrian L Harris; Vincenzo Cerundolo
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

10.  Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.

Authors:  David C Tscharke; Gunasegaran Karupiah; Jie Zhou; Tara Palmore; Kari R Irvine; S M Mansour Haeryfar; Shanicka Williams; John Sidney; Alessandro Sette; Jack R Bennink; Jonathan W Yewdell
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

View more
  10 in total

1.  Defective antiviral CD8 T-cell response and viral clearance in the absence of c-Jun N-terminal kinases.

Authors:  Yong-Qin Wang; Xi Ma; Lingling Lu; Limei Zhao; Xiaoqing Zhang; Qingyu Xu; Yang Wang
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

2.  Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus.

Authors:  Inge E A Flesch; Natasha A Hollett; Yik Chun Wong; Bárbara Resende Quinan; Debbie Howard; Flávio G da Fonseca; David C Tscharke
Journal:  J Immunol       Date:  2015-07-20       Impact factor: 5.422

3.  Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response.

Authors:  Tracy J Yuen; Inge E A Flesch; Natasha A Hollett; Bianca M Dobson; Tiffany A Russell; Aude M Fahrer; David C Tscharke
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

4.  Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.

Authors:  Julia Kim; Vandana Gambhir; Attiya Alatery; Sameh Basta
Journal:  J Biomed Biotechnol       Date:  2010-05-23

5.  Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Authors:  Scott A Brown; Sherri L Surman; Robert Sealy; Bart G Jones; Karen S Slobod; Kristen Branum; Timothy D Lockey; Nanna Howlett; Pamela Freiden; Patricia Flynn; Julia L Hurwitz
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.048

6.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

7.  Linear fidelity in quantification of anti-viral CD8+ T cells.

Authors:  Inge E A Flesch; Natasha A Hollett; Yik Chun Wong; David C Tscharke
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

8.  Cross-priming induces immunodomination in the presence of viral MHC class I inhibition.

Authors:  Elvin J Lauron; Liping Yang; Jabari I Elliott; Maria D Gainey; Daved H Fremont; Wayne M Yokoyama
Journal:  PLoS Pathog       Date:  2018-02-14       Impact factor: 6.823

9.  Immunodomination during peripheral vaccinia virus infection.

Authors:  Leon C W Lin; Inge E A Flesch; David C Tscharke
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

10.  Surprisingly Effective Priming of CD8+ T Cells by Heat-Inactivated Vaccinia Virus Virions.

Authors:  Sarah Croft; Yik Chun Wong; Stewart A Smith; Inge E A Flesch; David C Tscharke
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.